Rephonic
Artwork for Prostate Cancer Update

Prostate Cancer Update

Dr. Neil Love
Prostate Cancer
Pembrolizumab
Urothelial Bladder Cancer
Immunotherapy
Renal Cell Carcinoma
Clinical Trials
Urethral Bladder Cancer
Hormonal Therapy
PARP Inhibitors
Androgen Receptor Pathway Inhibitors
Metastatic Urothelial Bladder Cancer
AKT Inhibitors
EMBARQ Study
Chemotherapy
Bladder Cancer
Antibody-Drug Conjugates
HER2
Tar-200
P10 Deficiency
Nivolumab

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.

PublishesDailyEpisodes178Founded20 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Prostate Cancer Update

Latest Episodes

Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:

• Treatment approach for AKT-mutated prostate cancer — Question from Neeraj Agarwal, MD, FASCO (0:00)

• Ca... more

Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:

• Role of PTEN deficiency in tumorigenesis of prostate cancer and optimal approach to PTEN assessment — Qu... more

Featuring perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics:

• Introduction: Welcome GU Oncology Fellows! (0:00)

• Prostate Cancer — Dr Aggarwal (12:48)

• Urothelial Bladder Cancer — Dr Galsky... more

YouTube

Featuring perspectives from Prof Yohann Loriot, including the following topics:

• Case: A man in his early 80s with metastatic urothelial bladder cancer (mUBC) receives enfortumab vedotin (EV)/pembrolizumab but experiences immune-related adverse eve... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
Lung Cancer Update
Lung Cancer UpdateDr. Neil Love
The Peter Attia Drive
The Peter Attia DrivePeter Attia, MD

Recent Guests

Dr. Rana McKay
Faculty guest from the University of California, San Diego
University of California, San Diego
Episode: Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Alexandra Drakaki
Oncologist from UCLA; discussed neoadjuvant/perioperative strategies
University of California, Los Angeles
Episode: For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Rita Huber
Nurse practitioner focusing on GU malignancies; discussed tolerability and toxicity management of immunotherapies
Stanford Health Care
Episode: For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Krisztina Emodi
Nurse practitioner; bladder cancer survivor program lead; presented on basic biology and surgical considerations
University of California San Francisco
Episode: For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Ashish Kamat
Medical oncologist from the University of Texas, MD Anderson Cancer Center
University of Texas, MD Anderson Cancer Center
Episode: Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
Tom Powles
Professor at Barts Cancer Institute, Queen Mary University of London
Barts Cancer Institute, Queen Mary University of London
Episode: Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
Neeraj Agarwal
Professor from the University of Utah, Huntsman Cancer Institute
University of Utah, Huntsman Cancer Institute
Episode: Prostate Cancer — Fifth Annual National General Medical Oncology Summit
Alan Bryce
Research oncologist discussing translational data
Translational Genomics Research Institute at City of Hope
Episode: Prostate Cancer — Fifth Annual National General Medical Oncology Summit
Uday Dandamoni
Clinician from Florida Cancer Specialists
Florida Cancer Specialists
Episode: Prostate Cancer — Fifth Annual National General Medical Oncology Summit

Hosts

Dr. Neil Love
Host of the show, medical oncologist guiding the interview
Elisabeth Heath
Moderator of the session
Terence Friedlander
Moderator and physician providing clinical perspective on bladder cancer therapies (UCSF affiliation appears in records)

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#156
India/Science
Apple Podcasts
#237
Israel/Science
Apple Podcasts
#239
Philippines/Science

Talking Points

Recent interactions between the hosts and their guests.

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress
Q: Is one perioperative regimen better than the other, and how should nurses counsel patients?
The choice depends on patient-specific factors such as cisplatin eligibility, kidney function, neuropathy risk, and tumor characteristics; both regimens have distinct toxicity profiles, so counseling should emphasize side effects, monitoring needs, and shared decision-making based on patient priorities.
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Q: Given the toxicity signals with combination regimens, how do you balance upfront toxicity with long-term benefit?
The panel discusses weighing higher early toxicity against potential long-term benefits, with emphasis on selecting patients carefully, optimizing dosing cycles, and considering alternative sequences like monotherapy or different targeted approaches when toxicity risks rise.
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Q: Dan, what were your highlights of the year?
Dr. Petrylak points to EV Pembrolizumab studies opening new treatment frontiers for cisplatin-eligible and ineligible patients, the dramatic improvements in complete response rates, median survival, and the potential of ctDNA to guide adjuvant decisions.
Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Q: How does ctDNA positivity compare to PSA in guiding decisions for bladder cancer, and what are the practical implications for adjuvant therapy?
ctDNA provides a real-time, dynamic risk assessment that complements imaging. While PSA has long guided prostate cancer decisions, ctDNA offers a similar, time-sensitive signal in bladder cancer, enabling you to identify high-risk patients who may benefit from adjuvant immunotherapy and avoid overtreating those at low risk.
Metastatic Bladder Cancer — Rapid Case Review Issue 2
Q: When you're giving urtifitinib, how often are you having to do dose reductions to manage to keep patients on therapy?
Dose reductions are often necessary due to adverse effects, such as hand-foot syndrome.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Prostate Cancer Update

What is Prostate Cancer Update about and what kind of topics does it cover?

This series pulls from leading prostate cancer researchers and clinicians to translate cutting-edge research into practical insight for patient care. Episodes cover treatment strategies across the disease spectrum—from androgen-deprivation therapies and novel hormonal agents to chemotherapy, radiopharmaceuticals, and emerging biomarker-driven approaches like ctDNA. Hosts guide tight, clinician-to-clinician discussions that blend trial data, real-world experience, safety considerations, and patient-centered decision making, with an emphasis on sequencing, toxicity management, and shared decision making in everyday practice. Noteworthy aspects include a strong focus on integrating translational findings into clinical pathways, multidisciplina... more

Where can I find podcast stats for Prostate Cancer Update?

Rephonic provides a wide range of podcast stats for Prostate Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Prostate Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Prostate Cancer Update get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Prostate Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Prostate Cancer Update?

Rephonic provides comprehensive predictive audience data for Prostate Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Prostate Cancer Update have?

To see how many followers or subscribers Prostate Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Prostate Cancer Update?

These podcasts share a similar audience with Prostate Cancer Update:

1. Gastrointestinal Cancer Update
2. Two Onc Docs
3. Lung Cancer Update
4. The Peter Attia Drive
5. Breast Cancer Update

How many episodes of Prostate Cancer Update are there?

Prostate Cancer Update launched 20 years ago and published 178 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Prostate Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Prostate Cancer Update?

Rephonic pulls ratings and reviews for Prostate Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Prostate Cancer Update?

Rephonic provides full transcripts for episodes of Prostate Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Prostate Cancer Update?

Recent guests on Prostate Cancer Update include:

1. Dr. Rana McKay
2. Alexandra Drakaki
3. Rita Huber
4. Krisztina Emodi
5. Ashish Kamat
6. Tom Powles
7. Neeraj Agarwal
8. Alan Bryce

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days